Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE907.95-12.15 (-1.32 %)

PREV CLOSE ( ) 920.10

OPEN PRICE ( ) 923.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8891

TODAY'S LOW / HIGH ( )898.20 929.60

52 WK LOW / HIGH ( )530.7 1675.25

NSE908.15-12.1 (-1.31 %)

PREV CLOSE( ) 920.25

OPEN PRICE ( ) 920.00

BID PRICE (QTY) 908.15 (4)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 295317

TODAY'S LOW / HIGH( ) 897.10 931.00

52 WK LOW / HIGH ( )513.05 1675

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

11903.93

11536.67

12011.1

10875.05

Total Expenditure

9725.25

9433.55

9653.03

8705.24

PBIDT (Excl OI)

2178.68

2103.12

2358.07

2169.81

Other Income

119.79

56.16

284.11

127.16

Operating Profit

2298.47

2159.28

2642.18

2296.97

Interest

503.22

521.82

821.49

803.89

Exceptional Items

-274.15

-24.29

-38.72

-37.37

PBDT

1521.1

1613.17

1781.97

1455.71

Depreciation

488.6

484.24

505.24

485.94

Profit Before Tax

1032.5

1128.93

1276.73

969.77

Tax

207.59

238.05

212.03

168.61

Provisions and contingencies

Profit After Tax

824.91

890.88

1064.7

801.16

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

824.91

890.88

1064.7

801.16

Minority Interest

-34.24

-20.94

-4.29

18.9

Shares of Associates

31.27

9.52

-128.09

-118.04

Other related items

Misc. Expenses Written off

Consolidated Net Profit

821.94

879.46

932.32

702.02

Equity Capital

921.63

919.58

919.17

Face Value (IN RS)

Reserves

Calculated EPS

8.91

9.54

10.13

7.63

Calculated EPS (Annualised)

35.67

38.16

40.55

30.55

No of Public Share Holdings

66084869

67441890

68196887

68149172

% of Public Share Holdings

71.7

73.18

74.16

74.14

PBIDTM% (Excl OI)

18.30

18.22

19.63

19.95

PBIDTM%

19.30

18.71

21.99

21.12

PBDTM%

12.77

13.98

14.83

13.38

PBTM%

8.67

9.78

10.62

8.91

PATM%

6.92

7.72

8.86

7.36

Notes

Risk Disclosures on Derivatives

Quarterly Results

STRIDES PHARMA SCIENCE LTD.